October 31, 1996
FDA VETERINARY MEDICINE ADVISORY COMMITTEE TO MEET
The Food and Drug Administration's Veterinary Medicine Advisory Committee will convene on November 20, 1996, 8:30 a.m., in the Grand Ballroom of the Best Western, 1251 West Montgomery Avenue, Rockville, Maryland. The meeting will be open to the public for the entire day, with an opportunity for public participation in the afternoon.
The committee will discuss the status of the sometribove (Posilac®) Post-Approval Monitoring Program. FDA approved sometribove, a recombinant bovine somatotropin, on November 12, 1993, and the product (Posilac®) began commercial distribution on February 4, 1994.
Any interested person may present data, information, or views, orally or in writing, on issues pending before the committee. For further information, contact:
Richard E. Geyer
FDA/Center for Veterinary Medicine (HFV-244)
7500 Standish Place
Rockville, MD 20855
Telephone: 301-594-1764
Fax: 301-594-1807
An FDA Advisory Committee Information Hotline is available on 1-800-741-8138 (301-443-0572 in the Washington, DC area), Veterinary Medicine Advisory Committee, code 12546. Please call the Hotline for information concerning any possible changes.
Issued by:
FDA, Center for Veterinary Medicine,
Communications Staff, HFV-12
7519 Standish Place, Rockville, MD 20855
Telephone: (240) 276-9300 FAX: (240) 276-9115
Internet Web Site: http://www.fda.gov/cvm
|
||||||
 |
||||||
|
||||||